FI945807A0 - 2,5-diokso-2,5-dihydro-1H-bents/b/atsepiinit NMDA-reseptorin antagonisteina - Google Patents
2,5-diokso-2,5-dihydro-1H-bents/b/atsepiinit NMDA-reseptorin antagonisteinaInfo
- Publication number
- FI945807A0 FI945807A0 FI945807A FI945807A FI945807A0 FI 945807 A0 FI945807 A0 FI 945807A0 FI 945807 A FI945807 A FI 945807A FI 945807 A FI945807 A FI 945807A FI 945807 A0 FI945807 A0 FI 945807A0
- Authority
- FI
- Finland
- Prior art keywords
- benz
- azepines
- dioxo
- dihydro
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9212308 | 1992-06-10 | ||
GB929212308A GB9212308D0 (en) | 1992-06-10 | 1992-06-10 | Therapeutic compositions |
PCT/GB1993/001218 WO1993025534A1 (en) | 1992-06-10 | 1993-06-09 | 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS |
GB9301218 | 1993-06-09 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI945807A FI945807A (fi) | 1994-12-09 |
FI945807A0 true FI945807A0 (fi) | 1994-12-09 |
FI106714B FI106714B (fi) | 2001-03-30 |
Family
ID=10716859
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI945807A FI106714B (fi) | 1992-06-10 | 1994-12-09 | Menetelmä terapeuttisesti käyttökelpoisten 2,5-diokso-2,5-dihydro-1H-bents[b]atsepiiniyhdisteiden valmistamiseksi |
FI20002725A FI20002725A (fi) | 1992-06-10 | 2000-12-12 | 2,5-diokso-2,5-dihydro-1Hbents[b]atsepiinit NMDA-reseptorin antagonisteina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20002725A FI20002725A (fi) | 1992-06-10 | 2000-12-12 | 2,5-diokso-2,5-dihydro-1Hbents[b]atsepiinit NMDA-reseptorin antagonisteina |
Country Status (18)
Country | Link |
---|---|
US (3) | US5492905A (fi) |
EP (1) | EP0644878B1 (fi) |
JP (1) | JPH09502157A (fi) |
KR (1) | KR100298377B1 (fi) |
AT (1) | ATE205480T1 (fi) |
AU (1) | AU672799B2 (fi) |
CA (1) | CA2137834A1 (fi) |
DE (1) | DE69330754T2 (fi) |
DK (1) | DK0644878T3 (fi) |
ES (1) | ES2161718T3 (fi) |
FI (2) | FI106714B (fi) |
GB (1) | GB9212308D0 (fi) |
HU (1) | HUT71404A (fi) |
NO (1) | NO305168B1 (fi) |
NZ (1) | NZ253252A (fi) |
PT (1) | PT644878E (fi) |
RU (1) | RU94046322A (fi) |
WO (1) | WO1993025534A1 (fi) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9212308D0 (en) * | 1992-06-10 | 1992-07-22 | Ici Plc | Therapeutic compositions |
GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
US5476933A (en) * | 1994-11-16 | 1995-12-19 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Azepine synthesis via a diels-alder reaction |
MY133587A (en) | 2002-05-29 | 2007-11-30 | Glaxo Group Ltd | Aromatic sulfones and their medical use |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
KR20090115951A (ko) | 2007-03-01 | 2009-11-10 | 프로비오드룩 아게 | 글루타미닐 사이클라제 저해제의 신규 용도 |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
US8513263B2 (en) | 2008-10-22 | 2013-08-20 | Array Biopharma Inc. | Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors |
JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
EP2545047B9 (en) | 2010-03-10 | 2015-06-10 | Probiodrug AG | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
JPWO2016199789A1 (ja) * | 2015-06-08 | 2018-03-29 | 国立大学法人名古屋大学 | トリフルオロメチル置換セミスクアレートの製造方法、トリフルオロメチル置換セミスクアレートを起点とするトリフルオロメチル化合物の製造方法及びトリフルオロメチル基含有化合物 |
SI3800189T1 (sl) * | 2016-05-18 | 2023-11-30 | Loxo Oncology, Inc. | Priprava (s)-n-(5-((r)-2-(2,5-difluorofenil)pirolidin-1-il)pirazolo (1,5-a)pirimidin-3-il)-3-hidroksipirolidin-1-karboksamida |
DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB130538A (en) * | 1918-12-13 | 1919-08-07 | John Algernon Launder | Improvements in or relating to Means for Supporting Garments and Garment Hangers. |
GB1340334A (en) * | 1970-07-06 | 1973-12-12 | Rees A H | Synthesis of benzazetropolones and hence of kynurenic acids |
JPS5129522B2 (fi) * | 1972-07-13 | 1976-08-26 | ||
JPS5520970B2 (fi) * | 1972-07-15 | 1980-06-06 | ||
DE3269625D1 (en) * | 1981-08-11 | 1986-04-10 | Ciba Geigy Ag | Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use |
US4410520A (en) * | 1981-11-09 | 1983-10-18 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
US4473575A (en) * | 1982-07-19 | 1984-09-25 | Ciba-Geigy Corporation | 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids |
US4575503A (en) * | 1983-02-10 | 1986-03-11 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
DE3323568C2 (de) * | 1983-06-30 | 1987-01-29 | Bayerische Motoren Werke AG, 8000 München | Heiz- und/oder Klimaanlage für Kraftfahrzeuge |
US4477446A (en) * | 1983-07-01 | 1984-10-16 | Usv Pharmaceutical Corporation | 1-Benzazepines and their pharmaceutical uses |
DE3416695A1 (de) * | 1984-05-05 | 1985-11-07 | Bayer Ag, 5090 Leverkusen | Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
EP0450097B1 (en) * | 1989-10-20 | 1996-04-24 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
GB9100028D0 (en) * | 1991-01-02 | 1991-02-20 | Ici Plc | Compounds |
JPH05105292A (ja) * | 1991-10-15 | 1993-04-27 | Nec Corp | ロール紙のカール解消装置 |
GB9212308D0 (en) * | 1992-06-10 | 1992-07-22 | Ici Plc | Therapeutic compositions |
DE69334237D1 (de) * | 1992-06-22 | 2008-09-25 | State Of Oregon Through Oregon | Glycinrezeptorantagonisten und ihre verwendung |
GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
-
1992
- 1992-06-10 GB GB929212308A patent/GB9212308D0/en active Pending
-
1993
- 1993-06-09 AT AT93913323T patent/ATE205480T1/de not_active IP Right Cessation
- 1993-06-09 DE DE69330754T patent/DE69330754T2/de not_active Expired - Fee Related
- 1993-06-09 AU AU43436/93A patent/AU672799B2/en not_active Ceased
- 1993-06-09 EP EP93913323A patent/EP0644878B1/en not_active Expired - Lifetime
- 1993-06-09 NZ NZ253252A patent/NZ253252A/en unknown
- 1993-06-09 DK DK93913323T patent/DK0644878T3/da active
- 1993-06-09 JP JP6501262A patent/JPH09502157A/ja not_active Ceased
- 1993-06-09 HU HU9403498A patent/HUT71404A/hu unknown
- 1993-06-09 ES ES93913323T patent/ES2161718T3/es not_active Expired - Lifetime
- 1993-06-09 PT PT93913323T patent/PT644878E/pt unknown
- 1993-06-09 WO PCT/GB1993/001218 patent/WO1993025534A1/en active IP Right Grant
- 1993-06-09 CA CA002137834A patent/CA2137834A1/en not_active Abandoned
- 1993-06-09 KR KR1019940704503A patent/KR100298377B1/ko not_active IP Right Cessation
- 1993-06-09 RU RU94046322/14A patent/RU94046322A/ru unknown
- 1993-06-10 US US08/074,907 patent/US5492905A/en not_active Expired - Fee Related
-
1994
- 1994-12-09 NO NO944781A patent/NO305168B1/no unknown
- 1994-12-09 FI FI945807A patent/FI106714B/fi not_active IP Right Cessation
-
1995
- 1995-09-07 US US08/524,557 patent/US5654295A/en not_active Expired - Fee Related
-
1997
- 1997-01-13 US US08/782,279 patent/US5712272A/en not_active Expired - Fee Related
-
2000
- 2000-12-12 FI FI20002725A patent/FI20002725A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
WO1993025534A1 (en) | 1993-12-23 |
US5492905A (en) | 1996-02-20 |
PT644878E (pt) | 2002-02-28 |
DK0644878T3 (da) | 2002-03-18 |
NO944781L (no) | 1995-01-30 |
AU672799B2 (en) | 1996-10-17 |
NO305168B1 (no) | 1999-04-12 |
US5712272A (en) | 1998-01-27 |
US5654295A (en) | 1997-08-05 |
DE69330754D1 (de) | 2001-10-18 |
HUT71404A (en) | 1995-11-28 |
AU4343693A (en) | 1994-01-04 |
EP0644878B1 (en) | 2001-09-12 |
FI106714B (fi) | 2001-03-30 |
NO944781D0 (no) | 1994-12-09 |
GB9212308D0 (en) | 1992-07-22 |
RU94046322A (ru) | 1996-11-10 |
EP0644878A1 (en) | 1995-03-29 |
FI945807A (fi) | 1994-12-09 |
FI20002725A (fi) | 2000-12-12 |
ATE205480T1 (de) | 2001-09-15 |
NZ253252A (en) | 1996-11-26 |
CA2137834A1 (en) | 1993-12-23 |
ES2161718T3 (es) | 2001-12-16 |
DE69330754T2 (de) | 2002-07-04 |
KR100298377B1 (ko) | 2001-12-01 |
JPH09502157A (ja) | 1997-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI945807A0 (fi) | 2,5-diokso-2,5-dihydro-1H-bents/b/atsepiinit NMDA-reseptorin antagonisteina | |
UA29416C2 (uk) | Похідні 1,5 - бензодіазепіну, що є антагоністами гастрину та холецистокініну, спосіб їх одержання, фармацевтична композиція | |
NZ223772A (en) | Substituted benzodiazepine derivatives and pharmaceutical compositions | |
BG101715A (en) | Tetracyclic spiro compounds, process for their preparation and their use as 5ht 1 d receptor antagonists | |
IL146871A0 (en) | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases | |
MY121047A (en) | Bicyclo [2.2.1] heptanes and related compounds | |
IL127244A (en) | Substituted amines, methods of their preparation and pharmaceutical compositions containing them | |
IL132763A0 (en) | Novel compounds | |
MX9605023A (es) | Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas. | |
IL117824A (en) | Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia | |
IL104853A0 (en) | Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
ATE163409T1 (de) | Benz(b)azepin-2,5-dione verwendbar in der behandlung neurodegenerativer störungen | |
IL113365A (en) | 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
GR3034354T3 (en) | IMIDAZO 1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
BG102229A (en) | Endothelium receptor antagonists | |
BG101849A (en) | Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions | |
ITTO930661A1 (it) | Derivati acidi poliamidici ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico. | |
HUT68064A (en) | Process for preparing hexahydrobenzo[f]quinolinones | |
BR9714184A (pt) | Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas | |
HUP0001832A3 (en) | Polycyclic phthalazin derivatives, their use for ppolycyclic phthalazin derivatives, their use for producing pharmaceutical compositions and pharmaceuroducing pharmaceutical compositions and pharmaceutical compositions containing the compounds tical compositions containing the compounds | |
UA27715C2 (uk) | Похідні лактаму та фармацевтична композиція, яка є антагоністом 5-окситриптоміну /5-нт/ на 5-нт рецепторах | |
MX9804631A (es) | Antagonistas quinazolin-4-ona del ampa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |